Evaluating the expression of cyclooxygenase-2 enzyme by immunohistochemistry in normal and tumoral tissue before and after neoadjuvant chemoradiotherapy in patients with esophageal cancer in Khorasan Province | Zendy

Yousef Jalalabadi | Zendy; Alireza Shirazi | Zendy; Mohammad-Reza Ghavam–Nasiri | Zendy; Seyed Amir Aledavood | Zendy; Dariush Sardari | Zendy; Bahram Memar | Zendy; Soodabeh Shahidsales | Zendy; Fatemeh Varshoee-Tabrizi | Zendy; Parvane Dehghan | Zendy; Hassan Vosughiniya | Zendy

Open Access

Evaluating the expression of cyclooxygenase-2 enzyme by immunohistochemistry in normal and tumoral tissue before and after neoadjuvant chemoradiotherapy in patients with esophageal cancer in Khorasan Province

Author(s) -

Yousef Jalalabadi,

Alireza Shirazi,

Mohammad-Reza Ghavam–Nasiri,

Seyed Amir Aledavood,

Dariush Sardari,

Bahram Memar,

Soodabeh Shahidsales,

Fatemeh Varshoee-Tabrizi,

Parvane Dehghan,

Hassan Vosughiniya

Publication year - 2018

Publication title -

journal of cancer research and therapeutics

Language(s) - English

Resource type - Journals

SCImago Journal Rank - 0.475

H-Index - 39

eISSN - 0973-1482

pISSN - 1998-4138

DOI - 10.4103/0973-1482.199428

Subject(s) - medicine , immunohistochemistry , esophageal cancer , biopsy , cyclooxygenase , proportional hazards model , chemoradiotherapy , cancer , pathology , oncology , gastroenterology , enzyme , biochemistry , chemistry

Esophageal cancer is the third most common cancer in Iran. Neoadjuvant chemoradiotherapy (NCRT) is the appropriate treatment for esophageal cancer.

The content you want is available to Zendy users.

Already have an account? Click here to sign in.

Having issues? You can contact us here

Accelerating Research